Actively Recruiting
The Safety and Effectiveness of Palonosetron Hydrochloride Capsule Was Used to CINV
Led by Xijing Hospital · Updated on 2023-01-19
1060
Participants Needed
1
Research Sites
367 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To observe and evaluate the safety and effectiveness of Palonosetron hydrochloride capsule in preventing acute nausea and vomiting caused by moderate emetic chemotherapy; The characteristics of the applicable population, clinical medication and clinical benefits of Palonosetron Hydrochloride Capsules were analyzed.
CONDITIONS
Official Title
The Safety and Effectiveness of Palonosetron Hydrochloride Capsule Was Used to CINV
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with malignant tumors planning to receive chemotherapy with moderate risk of vomiting
- Age between 18 and 75 years
- Karnofsky Performance Status (KPS) score of 70 or higher
- Expected survival time longer than 3 months
- Normal ECG, blood tests, liver and kidney function, and electrolytes before treatment
- Signed informed consent form
You will not qualify if you...
- Patients with contraindications to chemotherapy
- Allergy to 5-HT3 receptor antagonists
- Pregnant or breastfeeding women
- Presence of digestive tract obstruction
- Serious heart, liver, kidney disease, or metabolic disorders
- History of epilepsy or current use of psychotropic or sedative drugs
- Use of antiemetic drugs or chemotherapy within 24 hours before treatment
- History of vomiting caused by brain metastasis, intracranial hypertension, gastrointestinal obstruction, psychological abnormalities, or other factors causing nausea and vomiting
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The First Affiliated Hospital, the Air Force Medical University
Xi'an, Shaan'xi, China, 710032
Actively Recruiting
Research Team
L
Liu Hong, master
CONTACT
W
Wei Zhou, master
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here